XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021   24,592,098      
Beginning balance at Dec. 31, 2021 $ 1,713,990 $ 246 $ 1,529,969 $ 174,572 $ 9,203
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 16,209   16,202 7  
Issuance of restricted stock, net (in shares)   434,068      
Issuance of restricted stock, net (2,868) $ 5 (2,873)    
Repurchase of common stock (in shares)   (571,789)      
Repurchase of common stock (36,916) $ (6) (35,396) (1,514)  
Common stock dividends (44,702)     (44,702)  
Foreign currency translation adjustment (74,677)       (74,677)
Unrealized (losses) gains on marketable securities, net of tax (895)       (895)
Net income 28,341     28,341  
Ending balance (in shares) at Sep. 30, 2022   24,454,377      
Ending balance at Sep. 30, 2022 1,598,482 $ 245 1,507,902 156,704 (66,369)
Beginning balance (in shares) at Jun. 30, 2022   24,637,268      
Beginning balance at Jun. 30, 2022 1,651,921 $ 246 1,513,509 166,175 (28,009)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 5,612   5,605 7  
Issuance of restricted stock, net (in shares)   (4,138)      
Issuance of restricted stock, net (90) $ 1 (91)    
Repurchase of common stock (in shares)   (178,753)      
Repurchase of common stock (11,944) $ (2) (11,121) (821)  
Common stock dividends (14,749)     (14,749)  
Foreign currency translation adjustment (38,171)       (38,171)
Unrealized (losses) gains on marketable securities, net of tax (189)       (189)
Net income 6,092     6,092  
Ending balance (in shares) at Sep. 30, 2022   24,454,377      
Ending balance at Sep. 30, 2022 $ 1,598,482 $ 245 1,507,902 156,704 (66,369)
Beginning balance (in shares) at Dec. 31, 2022 24,402,891 24,402,891      
Beginning balance at Dec. 31, 2022 $ 1,635,790 $ 244 1,510,924 159,690 (35,068)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 15,202   15,030 172  
Exercise of stock options, net (in shares)   2,704      
Exercise of stock options, net 126   126    
Issuance of restricted stock, net (in shares)   142,570      
Issuance of restricted stock, net (5,050) $ 1 (5,051)    
Repurchase of common stock (in shares)   (129,073)      
Repurchase of common stock (10,013) $ (1) (8,006) (2,006)  
Common stock dividends (44,153)     (44,153)  
Foreign currency translation adjustment (28,053)       (28,053)
Unrealized (losses) gains on marketable securities, net of tax 243       243
Net income $ 30,662     30,662  
Ending balance (in shares) at Sep. 30, 2023 24,419,092 24,419,092      
Ending balance at Sep. 30, 2023 $ 1,594,754 $ 244 1,513,023 144,365 (62,878)
Beginning balance (in shares) at Jun. 30, 2023   24,465,671      
Beginning balance at Jun. 30, 2023 1,598,606 $ 245 1,509,077 140,368 (51,084)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 4,077   3,905 172  
Exercise of stock options, net (in shares)   1,382      
Exercise of stock options, net 71   71    
Issuance of restricted stock, net (in shares)   (47,961)      
Issuance of restricted stock, net (31) $ (1) (30)    
Common stock dividends (14,634)     (14,634)  
Foreign currency translation adjustment (11,891)       (11,891)
Unrealized (losses) gains on marketable securities, net of tax 97       97
Net income $ 18,459     18,459  
Ending balance (in shares) at Sep. 30, 2023 24,419,092 24,419,092      
Ending balance at Sep. 30, 2023 $ 1,594,754 $ 244 $ 1,513,023 $ 144,365 $ (62,878)